Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Crizanlizumab |
| Trade Name | |
| Synonyms | Adakveo|SEG101|SEG-101|SEG 101 |
| Drug Descriptions |
Crizanlizumab is an antibody that inhibits P-selectin (SELP) (Cancer Res (2024) 84 (6_Supplement): 4031). |
| DrugClasses | |
| CAS Registry Number | 1690318-25-2 |
| NCIT ID | C133543 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Crizanlizumab | Crizanlizumab | 0 | 1 |
| Crizanlizumab + Nivolumab | Crizanlizumab Nivolumab | 0 | 1 |